Register or Login
  Search
  
You are here: Home > Health A to Z > Kernicterus

Health A to Z

 


Kernicterus

Definition
Expectations (prognosis)
Alternative Names
Complications
Causes, incidence, and risk factors
Calling your health care provider
Symptoms
Prevention
Signs and tests
References
Treatment


 Definition  

Kernicterus is a rare neurological condition that occurs in some newborns with severe jaundice.

See also: Newborn jaundice

 Alternative Names  

Bilirubin encephalopathy

 Causes, incidence, and risk factors  

Kernicterus is caused by very high levels of bilirubin. Bilirubin is a yellow pigment that is created in the body during the normal recycling of old red blood cells. High levels of bilirubin in the body can cause the skin to look yellow (which is called jaundice).

In some cases when there are extremely high levels of bilirubin in the body or the baby is extremely ill, the substance will move out of the blood and collect in the brain tissue. This can lead to serious neurological complications, including brain damage.

Kernicterus usually develops in the first week of life, but may be seen up until the third week. Newborns with Rh hemolytic disease that leads to hydrops fetalis are at high risk for severe jaundice that leads to this condition. However, kernicterus has been seen in apparently healthy babies.

 Symptoms  

The symptoms depend on the stage of kernicterus.

Early stage:

  • Extreme jaundice
  • Absent startle reflex
  • Poor breast-feeding or sucking
  • Extreme sleepiness (lethargy)

Mid stage:

  • High-pitched cry
  • Arched back with neck hyperextended backwards
  • Bulging fontanel (soft spot)
  • Seizures

Late stage (full neurological syndrome):

  • High-frequency hearing loss
  • Mental retardation
  • Muscle rigidity
  • Speech difficulties
  • Seizures
  • Movement disorder

 Signs and tests  

A blood test will show a high bilirubin level (greater than 20-25 mg/dL).

Note: Normal value ranges may vary slightly among different laboratories. Talk to your doctor about the meaning of your specific test results.

 Treatment  

  • Exchange transfusion (may require multiple exchanges)
  • Phototherapy

 Expectations (prognosis)  

Kernicterus represents an extreme condition caused by hemolysis. The outcome is guarded. Many infants with late stage neurological syndrome die.

 Complications  

  • Permanent brain damage
  • Death

 Calling your health care provider  

Seek immediate medical help if your baby has signs of this condition.

 Prevention  

Early diagnosis and treatment of jaundice or conditions that lead to jaundice may help prevent this complication. The American Academy of Pediatrics recommends that infants with the first signs of jaundice have their bilirubin level measured within 24 hours. If the level is high, the infant should be screened for diseases that involve the destruction of red blood cells (hemolysis).

The association also recommends that all newborns have a follow-up appointment within 2 to 3 days after leaving the hospital. This is particularly important for premature or near-term babies.

 References  

American Academy of Pediatrics, Subcommittee on Neonatal Hyperbilirubinemia: Neonatal jaundice and kernicterus. Pediatrics. 2001;108:763.

American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114: 297-316.

Behrman RE. Nelson Textbook of Pediatrics. 17th ed. Philadelphia, Pa: WB Saunders; 2004.

Review date: 10/11/2007

Reviewed By: Deirdre O'Reilly, MD, MPH, Neonatologist, Division of Newborn Medicine, Children's Hospital Boston and Instructor in Pediatrics, Harvard Medical School, Boston, Massachusetts. Review Provided by VeriMed Healthcare Network.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2008 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.


Home | Medical Info | Cool Tools
Who We Are | Editorial Guidelines | Contact Us | FAQ | Registration | Privacy

All contents copyright © Consumer Health Interactive, a division of Caremark, L.L.C. All rights reserved. Consumer Health Interactive makes this Web site available free to users for the sole purposes of providing educational information on health-related issues and providing access to health-related resources. This Web site's health-related information and resources are not intended to be a substitute for professional medical advice or for the care that patients receive from their physicians. Please review the Terms of Use before using this Web site. Your use of this Web site indicates your agreement to be bound by the Terms of Use. If you think you may have a medical emergency, call your doctor or 911 immediately.

This Web site was produced by
CAREMARK

We subscribe to the HONcode principles of the Health On the Net Foundation
We subscribe to the HONcode principles. Verify here.
URAC Health Web Site Accreditation Seal Editorial Team Medical Review Board
Medical Review Board and Editorial Team

-